Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK1 | Q13464 | 1/20 | 0.50 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 4/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | PKM | P14618 | 2/20 | 0.46 |
| ▸ | CLK1 | P49759 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 3/20 | 0.42 |
| ▸ | HTR2C | P28335 | 3/20 | 0.42 |
| ▸ | HTR2B | P41595 | 3/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | DRD2 | P14416 | 1/20 | 0.42 |
| ▸ | DRD4 | P21917 | 1/20 | 0.42 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11995386 | 1.00 | ROCK1 (0.50) | ROCK1NOTUMALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL15965528 | 1.00 | ROCK1 (0.50) | ROCK1NOTUMALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL25798923 | 0.88 | ROCK1 (0.47) | ROCK1NOTUMALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL13723399 | 0.82 | POLB (0.47) | ALDH1A1SMN1; SMN2HPGDPKM | |
| SCHEMBL22005465 | 0.79 | ROCK1 (0.51) | ROCK1NOTUMALDH1A1HPGDLMNA | |
| SCHEMBL7075121 | 0.79 | ROCK1 (0.51) | ROCK1NOTUMALDH1A1HPGDLMNA | |
| SCHEMBL12345961 | 0.76 | ROCK1 (0.49) | ROCK1NOTUMALDH1A1LMNAHTT | |
| SCHEMBL30421648 | 0.75 | ROCK1 (0.58) | ROCK1NOTUMALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL15681285 | 0.75 | ROCK1 (0.48) | ROCK1NOTUMALDH1A1HPGDLMNA | |
| SCHEMBL15714402 | 0.75 | NOTUM (0.54) | ROCK1NOTUMALDH1A1SMN1; SMN2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9837625-B2 | Organic electroluminescent element | Konica Minolta, Inc. (JP) | 2017-12-05 | — | — | US | disclosed |
| US-9780322-B2 | Organic electroluminescent element | Konica Minolta, Inc. (JP) | 2017-10-03 | — | — | US | disclosed |
| US-20160315273-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, LIGHTING DEVICE, AND DISPLAY DEVICE | Konica Minolta, Inc. (JP) | 2016-10-27 | — | — | US | disclosed |
| US-9437833-B2 | Organic electroluminescence element | Konica Minolta, Inc. (JP) | 2016-09-06 | — | — | US | disclosed |
| US-9260658-B2 | Organic electroluminescence element, lighting device and display device | Konica Minolta, Inc. (JP) | 2016-02-16 | — | — | US | disclosed |
| US-20150053949-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | Konica Minolta, Inc. (JP) | 2015-02-26 | — | — | US | disclosed |
| US-20140339529-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | Konica Minolta, Inc. (JP) | 2014-11-20 | — | — | US | disclosed |
| US-20140296476-A1 | PRODRUGS AND DRUG-MACROMOLECULE CONJUGATES HAVING CONTROLLED DRUG RELEASE RATES | PROLYNX LLC | 2014-10-02 | — | — | US | disclosed |
| US-20140191227-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT | Konica Minolta, Inc. (JP) | 2014-07-10 | — | — | US | disclosed |
| US-20130049576-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, LIGHTING DEVICE AND DISPLAY DEVICE | KONICA MINOLTA HOLDINGS, INC. (JP) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160315273-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, LIGHTING DEVICE, AND DISPLAY DEVICE | LAGE3, ELOVL1, ELP1 | ROCK1 3059/4885NOTUM 2319/4885ALDH1A1 768/4885 |
| US-20140296476-A1 | PRODRUGS AND DRUG-MACROMOLECULE CONJUGATES HAVING CONTROLLED DRUG RELEASE RATES | ABCB1, ABCB11, DNPEP | ROCK1 2066/4885NOTUM 1926/4885ALDH1A1 701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.